BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31595207)

  • 1. Subtyping of Parkinson's Disease - Where Are We Up To?
    Qian E; Huang Y
    Aging Dis; 2019 Oct; 10(5):1130-1139. PubMed ID: 31595207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Parkinson's Disease Subtypes and Related Attributes.
    Shakya S; Prevett J; Hu X; Xiao R
    Front Neurol; 2022; 13():810038. PubMed ID: 35677337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtyping of early-onset Parkinson's disease using cluster analysis: A large cohort study.
    Zhou Z; Zhou X; Xiang Y; Zhao Y; Pan H; Wu J; Xu Q; Chen Y; Sun Q; Wu X; Zhu J; Wu X; Li J; Yan X; Guo J; Tang B; Lei L; Liu Z
    Front Aging Neurosci; 2022; 14():1040293. PubMed ID: 36437996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?
    Fereshtehnejad SM; Postuma RB
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):34. PubMed ID: 28324303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.
    Albrecht F; Poulakis K; Freidle M; Johansson H; Ekman U; Volpe G; Westman E; Pereira JB; Franzén E
    Parkinsonism Relat Disord; 2022 Sep; 102():19-29. PubMed ID: 35932584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.
    Lee SH; Park SM; Yeo SS; Kwon O; Lee MK; Yoo H; Ahn EK; Jang JY; Jang JH
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtypes of Parkinson's disease: state of the field and future directions.
    Marras C
    Curr Opin Neurol; 2015 Aug; 28(4):382-6. PubMed ID: 26110797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmotor Subtyping in Parkinson's Disease.
    Sauerbier A; Rosa-Grilo M; Qamar MA; Chaudhuri KR
    Int Rev Neurobiol; 2017; 133():447-478. PubMed ID: 28802928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of Parkinson's disease subtypes using cluster analysis: a systematic review.
    van Rooden SM; Heiser WJ; Kok JN; Verbaan D; van Hilten JJ; Marinus J
    Mov Disord; 2010 Jun; 25(8):969-78. PubMed ID: 20535823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms.
    Mu J; Chaudhuri KR; Bielza C; de Pedro-Cuesta J; Larrañaga P; Martinez-Martin P
    Front Aging Neurosci; 2017; 9():301. PubMed ID: 28979203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.
    Mestre TA; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Marinus J; Mollenhauer B; Postuma R; Rajalingam R; Rodríguez-Violante M; Simuni T; Surmeier DJ; Weintraub D; McDermott MP; Lawton M; Marras C
    J Parkinsons Dis; 2021; 11(2):395-404. PubMed ID: 33682731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data-driven subtyping of Parkinson's disease: comparison of current methodologies and application to the Bochum PNS cohort.
    Chen Q; Scherbaum R; Gold R; Pitarokoili K; Mosig A; Zella S; Tönges L
    J Neural Transm (Vienna); 2023 Jun; 130(6):763-776. PubMed ID: 37000269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes.
    Boccalini C; Carli G; Pilotto A; Padovani A; Perani D
    Neurobiol Dis; 2022 Jun; 167():105668. PubMed ID: 35219854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes.
    Belvisi D; Fabbrini A; De Bartolo MI; Costanzo M; Manzo N; Fabbrini G; Defazio G; Conte A; Berardelli A
    Mov Disord; 2021 Feb; 36(2):370-379. PubMed ID: 33037859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feature selection and machine learning methods for optimal identification and prediction of subtypes in Parkinson's disease.
    Salmanpour MR; Shamsaei M; Rahmim A
    Comput Methods Programs Biomed; 2021 Jul; 206():106131. PubMed ID: 34015757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic architecture of Parkinson's disease subtypes - Review of the literature.
    Dulski J; Uitti RJ; Ross OA; Wszolek ZK
    Front Aging Neurosci; 2022; 14():1023574. PubMed ID: 36337703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year clinical progression in focal and diffuse subtypes of Parkinson's disease.
    Johansson ME; van Lier NM; Kessels RPC; Bloem BR; Helmich RC
    NPJ Parkinsons Dis; 2023 Feb; 9(1):29. PubMed ID: 36806285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-layer Trajectory Clustering: a Network Algorithm for Disease Subtyping.
    Krishnagopal S
    Biomed Phys Eng Express; 2020 Sep; 6(6):. PubMed ID: 35046146
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.